BiochemProbe — Life Science Research Reagents

ML218 free base · Synonyms: ML-218 · ML 218

ML218 is a potent, selective and orally active T-type Ca 2+ channels inhibitor.

For research use only. Not for human or veterinary use.

Research area Neurological Disease
Purity >98% Stock Inquire

ML218 structure

CAS No.: 1346233-68-8

Download structure (.mol)

Pack sizes & pricing

Size Price SKU Stock
50 mg USD 540.00 BP-01213-50mg In stock Get quote
100 mg USD 850.00 BP-01213-100mg In stock Get quote
250 mg USD 1,650.00 BP-01213-250mg In stock Get quote
500 mg USD 2,650.00 BP-01213-500mg In stock Get quote

Need another size or custom synthesis? Request a quote.

Description

ML218 is a potent, selective and orally active T-type Ca 2+ channels (Cav3.1, Cav3.2, Cav3.3) inhibitor with IC50s of 310 nM and 270 nM for Cav3.2 and Cav3.3, respectively. ML218 inhibits the burst activity in subthalamic nucleus (STN) neurons. ML218 has no significant inhibition of L- or N-type calcium channels, KATP or hERG potassium channels. ML218 can penetrate the blood-brain barrier .

Biological activity

In Vitro In plasma protein binding studies (equilibrium dialysis), ML218 possesses good free fraction in both rat and human. Intrinsic clearance experiments in liver microsomes indicated that ML218 is highly cleared in rat (CLint = 115 mL/min/kg), but low to moderately cleared in human liver microsomes (CLint = 12.7 mL/min/kg). In Vivo ML218 (0.03-30 mg/kg; oral administration; once; male Sprague-Dawley rats) treatment reverses cataleptic behavior in rats induced by a 0.75 mg/kg dose of haloperidol. Free brain and plasma concentrations of ML218 increases in a dose proportional manner across the dose range (3 mg/kg: [plasma] = 98 nM, [brain] = 1.66 μM; 10 mg/kg: [plasma] = 282 nM, [brain] = 5.03 μM; 30 mg/kg: 1.2 μM, [brain] = 17.7 μM). Noncompartmental pharmacokinetic analysis indicates ML218 (1 mg/kg, IV) has a mean residence time (MRT) of nearly 7 h, a value which is consistent with its terminal half-life (t1/2 = 7 h).

Identifiers

SMILES
O=C(NC[C@@H]1[C@@]2([H])CN(CCC(C)(C)C)C[C@@]12[H])C3=CC(Cl)=CC(Cl)=C3
InChIKey
GSJIGYLGKSBYBC-OSYLJGHBSA-N

Specifications

MW (average)
369.3290
Formula
C19H26Cl2N2O
CAS No.
1346233-68-8
Physical state
Solid
Color
White to off-white
Shipping
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage
Powder -20℃ 3 years, 4℃ 2 years; In solvent -20℃ 1 year;

Solubility

soluble in DMSO

References

[1]. Xiang Z, et al. The Discovery and Characterization of ML218: A Novel, Centrally Active T-Type Calcium Channel Inhibitor with Robust Effects in STN Neurons and in a Rodent Model of Parkinson's Disease. ACS Chem Neurosci. 2011 Dec 21;2(12):730-742.

Same research area

Search Neurological Disease